Lyra Therapeutics Inc (OQ:LYRA)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for LYRA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 23rd, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 20/24 Mar 18/24 Waksal Harlan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 275,000  
Mar 20/24 Mar 18/24 Palasis Maria Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 500,000  
Feb 1/24 Jan 30/24 Bishop John E Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 1/24 Jan 30/24 Nieman Richard Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 1/24 Jan 30/24 Cavalier Jason Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 200,000  
Nov 13/23 Nov 10/23 Waksal Harlan Direct Ownership Common Stock P - Open market or private purchase 25,000 $2.96
Jul 5/23 Jun 30/23 Tobin James R Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Jul 5/23 Jun 30/23 Smith W Bradford Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Jul 5/23 Jun 30/23 Poukalov Konstantin Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Jul 5/23 Jun 30/23 Altman Michael Seth Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LYRA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 23rd, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 20/24 Mar 18/24 Waksal Harlan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 275,000  
Mar 20/24 Mar 18/24 Palasis Maria Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 500,000  
Feb 1/24 Jan 30/24 Bishop John E Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 1/24 Jan 30/24 Nieman Richard Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 1/24 Jan 30/24 Cavalier Jason Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 200,000  
Nov 13/23 Nov 10/23 Waksal Harlan Direct Ownership Common Stock P - Open market or private purchase 25,000 $2.96
Jul 12/23 Jun 15/23 Palasis Maria Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 150,000  
Jul 5/23 Jun 30/23 Tobin James R Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Jul 5/23 Jun 30/23 Smith W Bradford Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Jul 5/23 Jun 30/23 Poukalov Konstantin Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LYRA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.